Limited-stage small-cell lung cancer (LS-SCLC) is treated with curative intent; however, relapses are common. Relapsed disease is typically treated with systemic therapy with palliative intent. However, some patients with oligorecurrent presentation may benefit from aggressive local therapy with a potential chance of long-term remission. In this case report, we review the case of a patient diagnosed with LS-SCLC after a thorough diagnostic and staging workup. She received 4 cycles of systemic chemotherapy, along with concurrent radiation therapy, followed by prophylactic cranial irradiation (PCI). Unfortunately, she developed two small metachronous brain metastases, 3 months and 12 months after PCI. Given no other disease activity on CT and subsequent positron emission tomography, she received stereotactic radiosurgery without systemic therapy. She remains in remission for >3 years with no evidence of disease without any need for ongoing active systemic therapy.
No takes yet. Share an insight, caveat, or question.
Shammas et al. (2025) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: